Cancer patients may soon skip hospital trips for skin rashes thanks to telemedicine
NCT ID NCT07476807
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether video consultations can safely assess and manage skin rashes caused by cancer treatments. Researchers will enroll 25 adult cancer patients with mild skin toxicity and see if telemedicine works as well as in-person visits. The goal is to reduce hospital visits while keeping care effective and safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- telemedicine assessment
- What this could lead to
- If successful, this could offer a convenient way for cancer patients to get skin issues checked from home, reducing hospital trips.
- What could go wrong
- This is a very small pilot study (25 people) with no comparison group, so results may not apply widely. Video assessments might miss serious problems that need in-person care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RASH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sligo university Hospital
Sligo, Sligo, f91h684, Ireland